跳至主要内容
临床试验/ACTRN12609000615280
ACTRN12609000615280招募中未知

Haemodiafiltration vs high-flux standard dialysis for uraemic neuropathy in people with end stage kidney disease

Statewide Renal Services0 个研究点目标入组 120 人开始时间: 2009年7月22日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Incident or prevalent patients requiring maintenance haemodialysis therapy for end stage kidney disease.
  • 2. Aged 18 years or older
  • 3. Suitable for either haemodiafiltration or standard dialysis in the view of the treating physician
  • 4. Agreeable to randomisation

排除标准

  • Patients will be excluded if, in the opinion or knowledge of the responsible clinician:
  • 1. Life expectancy is less than 6 months.
  • 2. Definite plans to undergo renal transplantation, transfer to a non-study site, transfer to peritoneal dialysis or transfer to home haemodialysis within 12 months of entry to the study.
  • 3. Unable or unwilling to complete neuropathy staging, including nerve conduction studies.
  • 4. Receiving haemodiafiltration

研究者

发起方
Statewide Renal Services

相似试验